Psychemedics Corporation PMD
2.67
0.00
0.00%
as of 2 Mar
- Market cap
- $15.7M
- P/E
- 0.0×
Follow PMD
| Dec '24 | Sep '24 | Jun '24 | Mar '24 | Older periods | |
|---|---|---|---|---|---|
| (31.54%) | (46.52%) | (61.33%) | (54.21%) |
+8 more TTM periods Free account |
|
| (18.03%) | (25.02%) | (34.41%) | (30.68%) | ||
ROIC |
(31.42%) | (44.64%) | (49.95%) | (36.35%) | |
Return on Tangible Assets |
(44.02%) | (66.70%) | (95.64%) | (93.62%) | |
Average Days of Receivables |
46.80 | 60.18 | 53.98 | 65.85 | |
Free Cash Flow per Share |
0.13 | 0.07 | (0.15) | (0.30) | |
Free Cash Flow |
0.79 | 0.42 | (0.85) | (1.77) | |
Capital Expenditures |
(0.14) | (0.15) | (0.20) | (0.04) | |
Piotroski F-Score |
6.00 | 6.00 | 5.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
14.08% | 8.28% | (9.05%) | (21.79%) | |
Accounts Receivable Turnover |
6.32 | 4.87 | 5.87 | 5.42 | |
Accounts Payable Turnover |
20.73 | 13.79 | 17.66 | 13.85 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
13.40 | 29.06 | 18.64 | 31.12 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.03) | 0.01 | 0.32 | 0.28 | |
Research and Development Expense of Revenue |
3.80% | 4.22% | 4.61% | 4.89% | |
Selling, General and Administrative Expense of Revenue |
41.88% | 48.60% | 49.58% | 47.39% | |
Share Based Compensation of Revenue |
4.66% | 4.99% | 5.64% | 4.76% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(0.50) | (0.19) | 0.14 | 0.39 | |
Depreciation/Fixed assets |
1.04 | 1.00 | 0.99 | 0.91 | |
Capex/Depreciation |
(0.07) | (0.07) | (0.08) | (0.02) | |
Revenue per Share |
3.36 | 3.44 | 3.57 | 3.72 | |
Operating CF per Share |
0.16 | 0.10 | (0.11) | (0.30) | |
Capex per Share |
(0.02) | (0.03) | (0.03) | (0.01) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.00 | |
Net Profit Margin |
(9.45%) | (14.78%) | (21.93%) | (20.64%) |
Columns are period end dates